DeutschNewstral
Article
Mmarketwatch.com on 2020-07-23 12:30
Biotech Nurix Therapeutics to offer 11 million shares in planned IPO, priced at $17 to $18 each
Related news
- MTrevi Therapeutics to offer 6.7 million shares in planned IPO priced at $14 to $16 eachmarketwatch.com
- MBiotech Oncorus to offer 5.8 million shares in planned IPO, priced at $14 to $16 eachmarketwatch.com
- MDyne Therapeutics to offer 10.3 million shares in IPO priced at $16 to $18 eachmarketwatch.com
- MBeam Therapeutics to offer 6.25 million shares in planned IPO priced at $15 to $17 eachmarketwatch.com
- MLyra Therapeutics to offer 3.5 million shares in planned IPO, priced at $14 to $16 eachmarketwatch.com
- MPandion Therapeutics upsizes planned IPO, to offer 7 million shares priced at $16 to $18 eachmarketwatch.com
- MADC Therapeutics to offer 8.1 million shares in planned IPO, priced at $23 to $26 eachmarketwatch.com
- MRapt Therapeutics to offer 3 million shares in planned IPO priced at $12 to $14 eachmarketwatch.com
- MPandion Therapeutics to offer 5.5 million shares in planned IPO, priced at $16 to $18 eachmarketwatch.com
- MBiotech Inhibrx to offer 6 million shares in planned IPO, priced at $16 to $18 eachmarketwatch.com
- MBiotech Alzheon to offer 6 million shares in planned IPO priced at $4 to $6 eachmarketwatch.com
- MProgenity to offer 6.7 million shares in planned IPO priced at $14 to $16 eachmarketwatch.com
- MHarmony Biosciences to offer 4.65 million shares in planned IPO, priced at $20 to $23 eachmarketwatch.com
- MBlack Diamond Therapeutics to offer 8.9 million shares in planned IPO, priced at $16 to $18 eachmarketwatch.com
- MAprea Therapeutics to offer 5 million shares in its IPO, priced at $14 to $16 eachmarketwatch.com
- MADC Therapeutics to offer 7.36 million shares in IPO, priced at $16 to $18 eachmarketwatch.com
- MFreeline Therapeutics to offer 7.35 million ADS in IPO, priced at $16 to $18 eachmarketwatch.com
- MTurning Point Therapeutics to sell 7.4 million shares in IPO, priced at $16 to $18 eachmarketwatch.com
- MGalera Therapeutics to offer 5 million shares in IPO priced at $14 to $16 eachmarketwatch.com
- MBiotech Arvinas to offer 6.7 million shares in IPO priced at $14 to $16 eachmarketwatch.com